These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7366300)

  • 21. Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds.
    Griffiths RR; Johnson MW
    J Clin Psychiatry; 2005; 66 Suppl 9():31-41. PubMed ID: 16336040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [What does the National Society for Help to Drug Addicts do for the hypnotic and sedative addicts?].
    Hofsten AM
    Lakartidningen; 1980 Feb; 77(6):430-1, 451. PubMed ID: 7366305
    [No Abstract]   [Full Text] [Related]  

  • 23. Relationship of brain ethanol metabolism to the hypnotic effect of ethanol. II: Studies in selectively bred rats and mice.
    Zimatkin SM; Liopo AV; Satanovskaya VI; Bardina And LR; Deitrich RA
    Alcohol Clin Exp Res; 2001 Jul; 25(7):982-8. PubMed ID: 11505022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of feedback inhibition on rat basolateral amygdala following stress or withdrawal from sedative-hypnotic drugs.
    Isoardi NA; Bertotto ME; Martijena ID; Molina VA; Carrer HF
    Eur J Neurosci; 2007 Aug; 26(4):1036-44. PubMed ID: 17666080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sleeping too soundly: the effects of sedative/hypnotic drug overdoses.
    Hertelendy AJ; Galtelli M; Brewer JM
    JEMS; 2003 Sep; 28(9):94-117, quiz 118-9. PubMed ID: 13679844
    [No Abstract]   [Full Text] [Related]  

  • 26. The road not taken: rationale for criteria for studying overdoses of drugs that depress the central nervous system.
    QRB Qual Rev Bull; 1977 Feb; 3(2):21-4. PubMed ID: 403490
    [No Abstract]   [Full Text] [Related]  

  • 27. Sedative-hypnotic profile of novel isatin ketals.
    Zapata-Sudo G; Pontes LB; Gabriel D; Mendes TC; Ribeiro NM; Pinto AC; Trachez MM; Sudo RT
    Pharmacol Biochem Behav; 2007 Apr; 86(4):678-85. PubMed ID: 17382995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral effects of photothrombotic ischemic cortical injury in aged rats treated with the sedative-hypnotic GABAergic drug zopiclone.
    Zhao CS; Puurunen K; Schallert T; Sivenius J; Jolkkonen J
    Behav Brain Res; 2005 May; 160(2):260-6. PubMed ID: 15863222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sedative and hypnotic activities of pyrimidine nucleoside derivatives.
    Kimura T; Teraoka S; Kuze J; Watanabe K; Kondo S; Ho IK; Yamamoto I
    Nucleic Acids Symp Ser; 1993; (29):51-2. PubMed ID: 8247791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The time-dependent effects of midazolam on regional cerebral glucose metabolism in rats.
    Freo U; Dam M; Ori C
    Anesth Analg; 2008 May; 106(5):1516-23, table of contents. PubMed ID: 18420870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is it safe to withdraw sedative drugs?
    LEVIN M
    Am J Psychiatry; 1956 May; 112(11):910-1. PubMed ID: 13313792
    [No Abstract]   [Full Text] [Related]  

  • 32. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
    Johnson MW; Suess PE; Griffiths RR
    Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress report from the testing program for stimulant and depressant drugs (1996).
    France CP; Gerak LR; Rowlett JK; Woolverton WL; Winger G; Woods JH
    NIDA Res Monogr; 1998 Mar; 178():429-39. PubMed ID: 9686406
    [No Abstract]   [Full Text] [Related]  

  • 34. Endogenous gamma-aminobutyric acid (GABA)(A) receptor active neurosteroids and the sedative/hypnotic action of gamma-hydroxybutyric acid (GHB): a study in GHB-S (sensitive) and GHB-R (resistant) rat lines.
    Barbaccia ML; Carai MA; Colombo G; Lobina C; Purdy RH; Gessa GL
    Neuropharmacology; 2005 Jul; 49(1):48-58. PubMed ID: 15992580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Zopiclone dependence. Report of one case].
    Pallavicini J; Acevedo X
    Rev Med Chil; 1997 Mar; 125(3):336-40. PubMed ID: 9460272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypnotic dependence: zolpidem and zopiclone too.
    Prescrire Int; 2001 Feb; 10(51):15. PubMed ID: 11503851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Personality characteristics of patients with exclusive abuse of sedative-hypnotic drugs.
    Holm L; Bergman H; Borg S
    Psychol Rep; 1982 Dec; 51(3 Pt 1):899-903. PubMed ID: 7163445
    [No Abstract]   [Full Text] [Related]  

  • 38. [Other sedatives and hypnotics-related disorders].
    Matsumoto C; Nakamura J
    Ryoikibetsu Shokogun Shirizu; 2003; (40):497-500. PubMed ID: 14626169
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pharmacotherapy of sleep disorders].
    Borbély AA
    Ther Umsch; 1993 Oct; 50(10):709-12. PubMed ID: 8153909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Determination of experimental habituation by a psychophysiological method. V. Study of several neuroplegic, tranquilizing and hypnotic drugs].
    MERCIER J; DESSAIGNE S; ETZENSPERGER P
    Ann Pharm Fr; 1962 Feb; 20():131-49. PubMed ID: 14472768
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.